The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice
CONCLUSIONS: The integration of new treatments into clinical practice should be informed by the potential for benefit relative to established therapies, as well as by the characteristics and preferences of individual patients.PMID:34160823 | DOI:10.1111/head.14153 (Source: Headache)
Source: Headache - June 23, 2021 Category: Neurology Authors: Jessica Ailani Rebecca C Burch Matthew S Robbins Board of Directors of the American Headache Society Source Type: research

Spontaneous spinal epidural hemorrhage and sentinel headache-A case report
CONCLUSION: Sentinel headache may be the sole symptom following spontaneous spinal epidural hemorrhage preceding both myelopathic and meningeal signs and symptoms. SSEH can best be diagnosed by lumbar puncture at this early moment potentially averting spinal cord injury.PMID:34153115 | DOI:10.1111/head.14143 (Source: Headache)
Source: Headache - June 21, 2021 Category: Neurology Authors: Joseph P Hanna John R Absher David S Enyart Source Type: research

Adaptation of the management of chronic migraine patients with medication overuse to the suspension of treatment protocols during the COVID-19 pandemic: Lessons from a tertiary headache center in Milan-6-month results
Headache. 2021 Jun 21. doi: 10.1111/head.14140. Online ahead of print.NO ABSTRACTPMID:34153116 | DOI:10.1111/head.14140 (Source: Headache)
Source: Headache - June 21, 2021 Category: Neurology Authors: Paul B Rizzoli Licia Grazzi Source Type: research

Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study
Headache. 2021 Jun 21. doi: 10.1111/head.14138. Online ahead of print.ABSTRACTOBJECTIVES: Erenumab is a human anti-calcitonin gene-related peptide receptor monoclonal antibody approved for migraine prevention. Global studies have demonstrated its efficacy in chronic and episodic migraine (EM). Here we report the outcomes from a Phase 3 study of erenumab in Japanese patients with chronic migraine (CM) or EM.METHODS: Japanese patients with EM (
Source: Headache - June 21, 2021 Category: Neurology Authors: Takao Takeshima Fumihiko Sakai Koichi Hirata Noboru Imai Yasuhiko Matsumori Ryuji Yoshida Cheng Peng Sunfa Cheng Daniel D Mikol Source Type: research

Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project
Headache. 2021 Jun 14. doi: 10.1111/head.14123. Online ahead of print.ABSTRACTOBJECTIVE: To develop a dedicated Italian chronic migraine (CM) database (IRON project) to overcome disease misconceptions, improve clinical administration, reduce patients' burden, and rationalize economic resource allotment.BACKGROUND: Proper CM management requires a comprehensive appraisal of its full clinical, social, and economic complexity.METHODS: In this cross-sectional study, CM patients were screened in 24 certified headache centers with face-to-face interviews. Information on sociodemographic factors, medical history, characteristics o...
Source: Headache - June 14, 2021 Category: Neurology Authors: Piero Barbanti Luisa Fofi Licia Grazzi Fabrizio Vernieri Cecilia Camarda Paola Torelli Sabina Cevoli Antonio Russo Francesco Bono Cinzia Finocchi Renata Rao Stefano Messina Roberto De Simone Nicola Vanacore Stefano Bonassi IRON Study Group Source Type: research

A new hypothesis linking oxytocin to menstrual migraine
CONCLUSION: Trigeminal OTR may thus be a novel target for the development of MRM therapeutics.PMID:34125955 | DOI:10.1111/head.14152 (Source: Headache)
Source: Headache - June 14, 2021 Category: Neurology Authors: Vimala N Bharadwaj Frank Porreca Robert P Cowan Shashidhar Kori Stephen D Silberstein David C Yeomans Source Type: research

Ten Eleven things to facilitate participation of underrepresented groups in headache medicine research
Headache. 2021 Jun 14. doi: 10.1111/head.14124. Online ahead of print.NO ABSTRACTPMID:34125956 | DOI:10.1111/head.14124 (Source: Headache)
Source: Headache - June 14, 2021 Category: Neurology Authors: Olivia Begasse de Dhaem Jessica Kiarashi Cynthia E Armand Larry Charleston Christina L Szperka Yeonsoo S Lee Thilinie Rajapakse Elizabeth K Seng Juliana H VanderPluym Amaal J Starling Source Type: research

Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project
Headache. 2021 Jun 14. doi: 10.1111/head.14123. Online ahead of print.ABSTRACTOBJECTIVE: To develop a dedicated Italian chronic migraine (CM) database (IRON project) to overcome disease misconceptions, improve clinical administration, reduce patients' burden, and rationalize economic resource allotment.BACKGROUND: Proper CM management requires a comprehensive appraisal of its full clinical, social, and economic complexity.METHODS: In this cross-sectional study, CM patients were screened in 24 certified headache centers with face-to-face interviews. Information on sociodemographic factors, medical history, characteristics o...
Source: Headache - June 14, 2021 Category: Neurology Authors: Piero Barbanti Luisa Fofi Licia Grazzi Fabrizio Vernieri Cecilia Camarda Paola Torelli Sabina Cevoli Antonio Russo Francesco Bono Cinzia Finocchi Renata Rao Stefano Messina Roberto De Simone Nicola Vanacore Stefano Bonassi IRON Study Group Source Type: research

A new hypothesis linking oxytocin to menstrual migraine
CONCLUSION: Trigeminal OTR may thus be a novel target for the development of MRM therapeutics.PMID:34125955 | DOI:10.1111/head.14152 (Source: Headache)
Source: Headache - June 14, 2021 Category: Neurology Authors: Vimala N Bharadwaj Frank Porreca Robert P Cowan Shashidhar Kori Stephen D Silberstein David C Yeomans Source Type: research

Ten Eleven things to facilitate participation of underrepresented groups in headache medicine research
Headache. 2021 Jun 14. doi: 10.1111/head.14124. Online ahead of print.NO ABSTRACTPMID:34125956 | DOI:10.1111/head.14124 (Source: Headache)
Source: Headache - June 14, 2021 Category: Neurology Authors: Olivia Begasse de Dhaem Jessica Kiarashi Cynthia E Armand Larry Charleston Christina L Szperka Yeonsoo S Lee Thilinie Rajapakse Elizabeth K Seng Juliana H VanderPluym Amaal J Starling Source Type: research

Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project
Headache. 2021 Jun 14. doi: 10.1111/head.14123. Online ahead of print.ABSTRACTOBJECTIVE: To develop a dedicated Italian chronic migraine (CM) database (IRON project) to overcome disease misconceptions, improve clinical administration, reduce patients' burden, and rationalize economic resource allotment.BACKGROUND: Proper CM management requires a comprehensive appraisal of its full clinical, social, and economic complexity.METHODS: In this cross-sectional study, CM patients were screened in 24 certified headache centers with face-to-face interviews. Information on sociodemographic factors, medical history, characteristics o...
Source: Headache - June 14, 2021 Category: Neurology Authors: Piero Barbanti Luisa Fofi Licia Grazzi Fabrizio Vernieri Cecilia Camarda Paola Torelli Sabina Cevoli Antonio Russo Francesco Bono Cinzia Finocchi Renata Rao Stefano Messina Roberto De Simone Nicola Vanacore Stefano Bonassi IRON Study Group Source Type: research

A new hypothesis linking oxytocin to menstrual migraine
CONCLUSION: Trigeminal OTR may thus be a novel target for the development of MRM therapeutics.PMID:34125955 | DOI:10.1111/head.14152 (Source: Headache)
Source: Headache - June 14, 2021 Category: Neurology Authors: Vimala N Bharadwaj Frank Porreca Robert P Cowan Shashidhar Kori Stephen D Silberstein David C Yeomans Source Type: research

Ten Eleven things to facilitate participation of underrepresented groups in headache medicine research
Headache. 2021 Jun 14. doi: 10.1111/head.14124. Online ahead of print.NO ABSTRACTPMID:34125956 | DOI:10.1111/head.14124 (Source: Headache)
Source: Headache - June 14, 2021 Category: Neurology Authors: Olivia Begasse de Dhaem Jessica Kiarashi Cynthia E Armand Larry Charleston Christina L Szperka Yeonsoo S Lee Thilinie Rajapakse Elizabeth K Seng Juliana H VanderPluym Amaal J Starling Source Type: research

Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project
Headache. 2021 Jun 14. doi: 10.1111/head.14123. Online ahead of print.ABSTRACTOBJECTIVE: To develop a dedicated Italian chronic migraine (CM) database (IRON project) to overcome disease misconceptions, improve clinical administration, reduce patients' burden, and rationalize economic resource allotment.BACKGROUND: Proper CM management requires a comprehensive appraisal of its full clinical, social, and economic complexity.METHODS: In this cross-sectional study, CM patients were screened in 24 certified headache centers with face-to-face interviews. Information on sociodemographic factors, medical history, characteristics o...
Source: Headache - June 14, 2021 Category: Neurology Authors: Piero Barbanti Luisa Fofi Licia Grazzi Fabrizio Vernieri Cecilia Camarda Paola Torelli Sabina Cevoli Antonio Russo Francesco Bono Cinzia Finocchi Renata Rao Stefano Messina Roberto De Simone Nicola Vanacore Stefano Bonassi IRON Study Group Source Type: research

A new hypothesis linking oxytocin to menstrual migraine
CONCLUSION: Trigeminal OTR may thus be a novel target for the development of MRM therapeutics.PMID:34125955 | DOI:10.1111/head.14152 (Source: Headache)
Source: Headache - June 14, 2021 Category: Neurology Authors: Vimala N Bharadwaj Frank Porreca Robert P Cowan Shashidhar Kori Stephen D Silberstein David C Yeomans Source Type: research

Ten Eleven things to facilitate participation of underrepresented groups in headache medicine research
Headache. 2021 Jun 14. doi: 10.1111/head.14124. Online ahead of print.NO ABSTRACTPMID:34125956 | DOI:10.1111/head.14124 (Source: Headache)
Source: Headache - June 14, 2021 Category: Neurology Authors: Olivia Begasse de Dhaem Jessica Kiarashi Cynthia E Armand Larry Charleston Christina L Szperka Yeonsoo S Lee Thilinie Rajapakse Elizabeth K Seng Juliana H VanderPluym Amaal J Starling Source Type: research

Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project
Headache. 2021 Jun 14. doi: 10.1111/head.14123. Online ahead of print.ABSTRACTOBJECTIVE: To develop a dedicated Italian chronic migraine (CM) database (IRON project) to overcome disease misconceptions, improve clinical administration, reduce patients' burden, and rationalize economic resource allotment.BACKGROUND: Proper CM management requires a comprehensive appraisal of its full clinical, social, and economic complexity.METHODS: In this cross-sectional study, CM patients were screened in 24 certified headache centers with face-to-face interviews. Information on sociodemographic factors, medical history, characteristics o...
Source: Headache - June 14, 2021 Category: Neurology Authors: Piero Barbanti Luisa Fofi Licia Grazzi Fabrizio Vernieri Cecilia Camarda Paola Torelli Sabina Cevoli Antonio Russo Francesco Bono Cinzia Finocchi Renata Rao Stefano Messina Roberto De Simone Nicola Vanacore Stefano Bonassi IRON Study Group Source Type: research

A new hypothesis linking oxytocin to menstrual migraine
CONCLUSION: Trigeminal OTR may thus be a novel target for the development of MRM therapeutics.PMID:34125955 | DOI:10.1111/head.14152 (Source: Headache)
Source: Headache - June 14, 2021 Category: Neurology Authors: Vimala N Bharadwaj Frank Porreca Robert P Cowan Shashidhar Kori Stephen D Silberstein David C Yeomans Source Type: research

Ten Eleven things to facilitate participation of underrepresented groups in headache medicine research
Headache. 2021 Jun 14. doi: 10.1111/head.14124. Online ahead of print.NO ABSTRACTPMID:34125956 | DOI:10.1111/head.14124 (Source: Headache)
Source: Headache - June 14, 2021 Category: Neurology Authors: Olivia Begasse de Dhaem Jessica Kiarashi Cynthia E Armand Larry Charleston Christina L Szperka Yeonsoo S Lee Thilinie Rajapakse Elizabeth K Seng Juliana H VanderPluym Amaal J Starling Source Type: research

Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real-life perspective from the Italian chROnic migraiNe (IRON) project
Headache. 2021 Jun 14. doi: 10.1111/head.14123. Online ahead of print.ABSTRACTOBJECTIVE: To develop a dedicated Italian chronic migraine (CM) database (IRON project) to overcome disease misconceptions, improve clinical administration, reduce patients' burden, and rationalize economic resource allotment.BACKGROUND: Proper CM management requires a comprehensive appraisal of its full clinical, social, and economic complexity.METHODS: In this cross-sectional study, CM patients were screened in 24 certified headache centers with face-to-face interviews. Information on sociodemographic factors, medical history, characteristics o...
Source: Headache - June 14, 2021 Category: Neurology Authors: Piero Barbanti Luisa Fofi Licia Grazzi Fabrizio Vernieri Cecilia Camarda Paola Torelli Sabina Cevoli Antonio Russo Francesco Bono Cinzia Finocchi Renata Rao Stefano Messina Roberto De Simone Nicola Vanacore Stefano Bonassi IRON Study Group Source Type: research

A new hypothesis linking oxytocin to menstrual migraine
CONCLUSION: Trigeminal OTR may thus be a novel target for the development of MRM therapeutics.PMID:34125955 | DOI:10.1111/head.14152 (Source: Headache)
Source: Headache - June 14, 2021 Category: Neurology Authors: Vimala N Bharadwaj Frank Porreca Robert P Cowan Shashidhar Kori Stephen D Silberstein David C Yeomans Source Type: research

Ten Eleven things to facilitate participation of underrepresented groups in headache medicine research
Headache. 2021 Jun 14. doi: 10.1111/head.14124. Online ahead of print.NO ABSTRACTPMID:34125956 | DOI:10.1111/head.14124 (Source: Headache)
Source: Headache - June 14, 2021 Category: Neurology Authors: Olivia Begasse de Dhaem Jessica Kiarashi Cynthia E Armand Larry Charleston Christina L Szperka Yeonsoo S Lee Thilinie Rajapakse Elizabeth K Seng Juliana H VanderPluym Amaal J Starling Source Type: research

Arachnoiditis following epidural blood patch-An avoidable rare complication due to blind technique: A response
Headache. 2021 Jun 11. doi: 10.1111/head.14146. Online ahead of print.NO ABSTRACTPMID:34115374 | DOI:10.1111/head.14146 (Source: Headache)
Source: Headache - June 11, 2021 Category: Neurology Authors: Seniha N Ozudogru Linda A Villani Melissa M Cortez Christina Bokat Ulrich A Rassner Kathleen B Digre Source Type: research

Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine
Headache. 2021 Jun 11. doi: 10.1111/head.14127. Online ahead of print.ABSTRACTOBJECTIVE: To evaluate the impact of fremanezumab on the severity and duration of remaining migraine attacks in patients with chronic migraine (CM) or episodic migraine (EM).BACKGROUND: Fremanezumab is a fully humanized monoclonal antibody (IgGΔa) that selectively targets calcitonin gene-related peptide and is efficacious in reducing migraine frequency.METHODS: This exploratory post hoc analysis included data from three randomized, double-blind, 12-week, phase 3 studies (HALO CM, HALO EM, and FOCUS). In all three studies, patients with CM o...
Source: Headache - June 11, 2021 Category: Neurology Authors: Messoud Ashina Joshua M Cohen Sanjay K Gandhi Evelyn Du Source Type: research

Acceptance and commitment therapy for high frequency episodic migraine without aura: Findings from a randomized pilot investigation
CONCLUSIONS: Our preliminary findings indicate that supplementing TAU with ACT can enhance the main clinical outcomes, namely headache frequency and medication intake of patients with HFEM.PMID:34115399 | DOI:10.1111/head.14139 (Source: Headache)
Source: Headache - June 11, 2021 Category: Neurology Authors: Licia Grazzi Frank Andrasik Paul Rizzoli Carolyn Bernstein Emanuela Sansone Alberto Raggi Source Type: research

Arachnoiditis following epidural blood patch-An avoidable rare complication due to blind technique: A response
Headache. 2021 Jun 11. doi: 10.1111/head.14146. Online ahead of print.NO ABSTRACTPMID:34115374 | DOI:10.1111/head.14146 (Source: Headache)
Source: Headache - June 11, 2021 Category: Neurology Authors: Seniha N Ozudogru Linda A Villani Melissa M Cortez Christina Bokat Ulrich A Rassner Kathleen B Digre Source Type: research

Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine
Headache. 2021 Jun 11. doi: 10.1111/head.14127. Online ahead of print.ABSTRACTOBJECTIVE: To evaluate the impact of fremanezumab on the severity and duration of remaining migraine attacks in patients with chronic migraine (CM) or episodic migraine (EM).BACKGROUND: Fremanezumab is a fully humanized monoclonal antibody (IgGΔa) that selectively targets calcitonin gene-related peptide and is efficacious in reducing migraine frequency.METHODS: This exploratory post hoc analysis included data from three randomized, double-blind, 12-week, phase 3 studies (HALO CM, HALO EM, and FOCUS). In all three studies, patients with CM o...
Source: Headache - June 11, 2021 Category: Neurology Authors: Messoud Ashina Joshua M Cohen Sanjay K Gandhi Evelyn Du Source Type: research

Acceptance and commitment therapy for high frequency episodic migraine without aura: Findings from a randomized pilot investigation
CONCLUSIONS: Our preliminary findings indicate that supplementing TAU with ACT can enhance the main clinical outcomes, namely headache frequency and medication intake of patients with HFEM.PMID:34115399 | DOI:10.1111/head.14139 (Source: Headache)
Source: Headache - June 11, 2021 Category: Neurology Authors: Licia Grazzi Frank Andrasik Paul Rizzoli Carolyn Bernstein Emanuela Sansone Alberto Raggi Source Type: research

Arachnoiditis following epidural blood patch-An avoidable rare complication due to blind technique: A response
Headache. 2021 Jun 11. doi: 10.1111/head.14146. Online ahead of print.NO ABSTRACTPMID:34115374 | DOI:10.1111/head.14146 (Source: Headache)
Source: Headache - June 11, 2021 Category: Neurology Authors: Seniha N Ozudogru Linda A Villani Melissa M Cortez Christina Bokat Ulrich A Rassner Kathleen B Digre Source Type: research

Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine
Headache. 2021 Jun 11. doi: 10.1111/head.14127. Online ahead of print.ABSTRACTOBJECTIVE: To evaluate the impact of fremanezumab on the severity and duration of remaining migraine attacks in patients with chronic migraine (CM) or episodic migraine (EM).BACKGROUND: Fremanezumab is a fully humanized monoclonal antibody (IgGΔa) that selectively targets calcitonin gene-related peptide and is efficacious in reducing migraine frequency.METHODS: This exploratory post hoc analysis included data from three randomized, double-blind, 12-week, phase 3 studies (HALO CM, HALO EM, and FOCUS). In all three studies, patients with CM o...
Source: Headache - June 11, 2021 Category: Neurology Authors: Messoud Ashina Joshua M Cohen Sanjay K Gandhi Evelyn Du Source Type: research

Acceptance and commitment therapy for high frequency episodic migraine without aura: Findings from a randomized pilot investigation
CONCLUSIONS: Our preliminary findings indicate that supplementing TAU with ACT can enhance the main clinical outcomes, namely headache frequency and medication intake of patients with HFEM.PMID:34115399 | DOI:10.1111/head.14139 (Source: Headache)
Source: Headache - June 11, 2021 Category: Neurology Authors: Licia Grazzi Frank Andrasik Paul Rizzoli Carolyn Bernstein Emanuela Sansone Alberto Raggi Source Type: research

Indomethacin-responsive headaches-A narrative review
CONCLUSION: Increasing understanding of the mechanism(s) of action of indomethacin will enhance our understanding of the complex pathophysiology that might be shared by indomethacin-sensitive headache disorders.PMID:34105154 | DOI:10.1111/head.14111 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: Maria Dolores Villar-Mart ínez David Moreno-Ajona Calvin Chan Peter J Goadsby Source Type: research

The status of intravenous dihydroergotamine for pediatric headache: Status migrainosus and beyond
Headache. 2021 May;61(5):698-699. doi: 10.1111/head.14114.NO ABSTRACTPMID:34105155 | DOI:10.1111/head.14114 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: Kaitlin A Greene Source Type: research

The importance of studying comorbidities in migraine
Headache. 2021 May;61(5):697. doi: 10.1111/head.14113.NO ABSTRACTPMID:34105156 | DOI:10.1111/head.14113 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: Jason Ziplow Source Type: research

Headache attributed to airplane travel: Time for a multicentric international survey?
Headache. 2021 May;61(5):794-795. doi: 10.1111/head.14107.NO ABSTRACTPMID:34105157 | DOI:10.1111/head.14107 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: Federico Mainardi Ferdinando Maggioni Carlo Lisotto Giorgio Zanchin Source Type: research

Dihydroergotamine infusion for pediatric refractory headache: A retrospective chart review
The objective of this study was to describe demographic and clinical characteristics of children admitted for DHE infusion, determine DHE treatment outcomes by means of numeric pain scale ratings, and explore associations between treatment outcomes and clinical characteristics.METHODS: Retrospective chart review was completed in patients ages 5-21 admitted for DHE infusion from January 2013 to July 2018 at a large, pediatric academic medical center and community-based satellite center. All primary headache types were included.RESULTS: A total of 200 unique admissions for DHE were available for analysis. Overall, patients w...
Source: Headache - June 9, 2021 Category: Neurology Authors: Rasha Srouji Sara R Schenkel Peter Forbes Jennifer E Cahill Source Type: research

Medication-overuse headache in patients with secondary headache disorders: Need for revision?
Headache. 2021 May;61(5):790-791. doi: 10.1111/head.14108.NO ABSTRACTPMID:34105159 | DOI:10.1111/head.14108 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: H åkan Ashina David W Dodick Source Type: research

Hemicrania continua secondary to pituitary macroadenoma responsive to nerve blocks: A case report
Headache. 2021 May;61(5):798-800. doi: 10.1111/head.14121.NO ABSTRACTPMID:34105160 | DOI:10.1111/head.14121 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: Tommy Lik Hang Chan Source Type: research

Validity and reliability of the self-administered Visual Aura Rating Scale questionnaire for migraine with aura diagnosis: A prospective clinic-based study
CONCLUSION: The self-administered VARS questionnaire is a valid and reliable instrument for the screening of visual aura in patients with migraine in neurology outpatient clinics.PMID:34106459 | DOI:10.1111/head.14133 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: Byung-Kun Kim Soohyun Cho Ha Yan Kim Min Kyung Chu Source Type: research

Could osmophobia be a clinical diagnostic marker for migraine?
Headache. 2021 Jun 9. doi: 10.1111/head.14148. Online ahead of print.NO ABSTRACTPMID:34106463 | DOI:10.1111/head.14148 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: Raimundo Pereira Silva-N éto Source Type: research

Headache attributed to idiopathic intracranial hypertension and persistent post-idiopathic intracranial hypertension headache: A narrative review
CONCLUSIONS: There is overwhelming evidence of the headache burden in IIH. Studies are required to investigate the biological foundations of headache related to ICP and to develop treatments specifically directed to manage headache in IIH.PMID:34106464 | DOI:10.1111/head.14125 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: Susan P Mollan Olivia Grech Alexandra J Sinclair Source Type: research

Indomethacin-responsive headaches-A narrative review
CONCLUSION: Increasing understanding of the mechanism(s) of action of indomethacin will enhance our understanding of the complex pathophysiology that might be shared by indomethacin-sensitive headache disorders.PMID:34105154 | DOI:10.1111/head.14111 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: Maria Dolores Villar-Mart ínez David Moreno-Ajona Calvin Chan Peter J Goadsby Source Type: research

The status of intravenous dihydroergotamine for pediatric headache: Status migrainosus and beyond
Headache. 2021 May;61(5):698-699. doi: 10.1111/head.14114.NO ABSTRACTPMID:34105155 | DOI:10.1111/head.14114 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: Kaitlin A Greene Source Type: research

The importance of studying comorbidities in migraine
Headache. 2021 May;61(5):697. doi: 10.1111/head.14113.NO ABSTRACTPMID:34105156 | DOI:10.1111/head.14113 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: Jason Ziplow Source Type: research

Headache attributed to airplane travel: Time for a multicentric international survey?
Headache. 2021 May;61(5):794-795. doi: 10.1111/head.14107.NO ABSTRACTPMID:34105157 | DOI:10.1111/head.14107 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: Federico Mainardi Ferdinando Maggioni Carlo Lisotto Giorgio Zanchin Source Type: research

Dihydroergotamine infusion for pediatric refractory headache: A retrospective chart review
The objective of this study was to describe demographic and clinical characteristics of children admitted for DHE infusion, determine DHE treatment outcomes by means of numeric pain scale ratings, and explore associations between treatment outcomes and clinical characteristics.METHODS: Retrospective chart review was completed in patients ages 5-21 admitted for DHE infusion from January 2013 to July 2018 at a large, pediatric academic medical center and community-based satellite center. All primary headache types were included.RESULTS: A total of 200 unique admissions for DHE were available for analysis. Overall, patients w...
Source: Headache - June 9, 2021 Category: Neurology Authors: Rasha Srouji Sara R Schenkel Peter Forbes Jennifer E Cahill Source Type: research

Medication-overuse headache in patients with secondary headache disorders: Need for revision?
Headache. 2021 May;61(5):790-791. doi: 10.1111/head.14108.NO ABSTRACTPMID:34105159 | DOI:10.1111/head.14108 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: H åkan Ashina David W Dodick Source Type: research

Hemicrania continua secondary to pituitary macroadenoma responsive to nerve blocks: A case report
Headache. 2021 May;61(5):798-800. doi: 10.1111/head.14121.NO ABSTRACTPMID:34105160 | DOI:10.1111/head.14121 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: Tommy Lik Hang Chan Source Type: research

Validity and reliability of the self-administered Visual Aura Rating Scale questionnaire for migraine with aura diagnosis: A prospective clinic-based study
CONCLUSION: The self-administered VARS questionnaire is a valid and reliable instrument for the screening of visual aura in patients with migraine in neurology outpatient clinics.PMID:34106459 | DOI:10.1111/head.14133 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: Byung-Kun Kim Soohyun Cho Ha Yan Kim Min Kyung Chu Source Type: research

Could osmophobia be a clinical diagnostic marker for migraine?
Headache. 2021 Jun 9. doi: 10.1111/head.14148. Online ahead of print.NO ABSTRACTPMID:34106463 | DOI:10.1111/head.14148 (Source: Headache)
Source: Headache - June 9, 2021 Category: Neurology Authors: Raimundo Pereira Silva-N éto Source Type: research